85 related articles for article (PubMed ID: 10728963)
21. [Clinical and hemodynamic efficacy of selective beta-blocker bisoprolol and cytoprotector trimetazidine in the treatment of chronic cardiac failure in patients with ischemic heart disease].
Fedorova TA; Il'ina IuV; Sotnikova TI; Rybakova MK; Loshchits NV
Ter Arkh; 2004; 76(3):62-8. PubMed ID: 15108463
[TBL] [Abstract][Full Text] [Related]
22. Tolerability of beta-blocker initiation and titration with bisoprolol and carvedilol in congestive heart failure -- a randomized comparison.
Galatius S; Gustafsson F; Atar D; Hildebrandt PR
Cardiology; 2004; 102(3):160-5. PubMed ID: 15334027
[TBL] [Abstract][Full Text] [Related]
23. Effects of carvedilol on systolic and diastolic left ventricular performance in idiopathic dilated cardiomyopathy or ischemic cardiomyopathy.
Quaife RA; Gilbert EM; Christian PE; Datz FL; Mealey PC; Volkman K; Olsen SL; Bristow MR
Am J Cardiol; 1996 Oct; 78(7):779-84. PubMed ID: 8857482
[TBL] [Abstract][Full Text] [Related]
24. Ser49Gly of beta1-adrenergic receptor is associated with effective beta-blocker dose in dilated cardiomyopathy.
Magnusson Y; Levin MC; Eggertsen R; Nyström E; Mobini R; Schaufelberger M; Andersson B
Clin Pharmacol Ther; 2005 Sep; 78(3):221-31. PubMed ID: 16153393
[TBL] [Abstract][Full Text] [Related]
25. Hypotensive and heart rate-lowering effects of low-dose bisoprolol determined based on self-measured blood pressure at home.
Satoh M; Obara T; Ikeda U; Kobayashi Y; Metoki H; Asayama K; Kikuya M; Ohkubo T; Imai Y
Clin Exp Hypertens; 2012; 34(4):284-9. PubMed ID: 22571411
[TBL] [Abstract][Full Text] [Related]
26. Beta-blocker therapy induces ventricular resynchronization in dilated cardiomyopathy with narrow QRS complex.
Takemoto Y; Hozumi T; Sugioka K; Takagi Y; Matsumura Y; Yoshiyama M; Abraham TP; Yoshikawa J
J Am Coll Cardiol; 2007 Feb; 49(7):778-83. PubMed ID: 17306707
[TBL] [Abstract][Full Text] [Related]
27. Pharmacological left ventricular reverse remodeling in elderly patients receiving optimal therapy for chronic heart failure.
Cioffi G; Tarantini L; De Feo S; Pulignano G; Del Sindaco D; Stefenelli C; Opasich C
Eur J Heart Fail; 2005 Oct; 7(6):1040-8. PubMed ID: 16227142
[TBL] [Abstract][Full Text] [Related]
28. Chronotropic incompentence and functional capacity in chronic heart failure: no role of β-blockers and β-blocker dose.
Magrì D; Palermo P; Cauti FM; Contini M; Farina S; Cattadori G; Apostolo A; Salvioni E; Magini A; Vignati C; Alimento M; Sciomer S; Bussotti M; Agostoni P
Cardiovasc Ther; 2012 Apr; 30(2):100-8. PubMed ID: 20553283
[TBL] [Abstract][Full Text] [Related]
29. A randomized trial of low-dose beta-blockade therapy for idiopathic dilated cardiomyopathy.
Anderson JL; Lutz JR; Gilbert EM; Sorensen SG; Yanowitz FG; Menlove RL; Bartholomew M
Am J Cardiol; 1985 Feb; 55(4):471-5. PubMed ID: 2857523
[TBL] [Abstract][Full Text] [Related]
30. Effect of the addition of a beta-blocker on left ventricular remodeling and prognosis in patients with dilated cardiomyopathy treated with angiotensin-converting enzyme inhibitor.
Hamada M; Hara Y; Ohtsuka T; Suzuki J; Saeki H; Ogimoto A; Shigematsu Y
J Cardiovasc Pharmacol; 2003 Jan; 41 Suppl 1():S5-10. PubMed ID: 12688389
[TBL] [Abstract][Full Text] [Related]
31. The effect of an evening dose of a long-acting beta-blocker on the autonomic tone in patients with congestive heart failure.
Targoński R; Sadowski J
Kardiol Pol; 2009 Sep; 67(9):963-70. PubMed ID: 19838952
[TBL] [Abstract][Full Text] [Related]
32. Heart rate-reducing effects of bisoprolol in Japanese patients with chronic atrial fibrillation: results of the MAIN-AF study.
Yamashita T; Inoue H
J Cardiol; 2013 Jul; 62(1):50-7. PubMed ID: 23611172
[TBL] [Abstract][Full Text] [Related]
33. Results from post-hoc analyses of the CIBIS II trial: effect of bisoprolol in high-risk patient groups with chronic heart failure.
Erdmann E; Lechat P; Verkenne P; Wiemann H
Eur J Heart Fail; 2001 Aug; 3(4):469-79. PubMed ID: 11511434
[TBL] [Abstract][Full Text] [Related]
34. Study of the effect of Tensiomin (captopril) in chronic heart failure.
Cserhalmi L; Istvánffy M; Hideg L; Török E
Acta Physiol Hung; 1988; 72 Suppl():85-91. PubMed ID: 3075405
[TBL] [Abstract][Full Text] [Related]
35. Study of the electrophysiological properties of intravenous bisoprolol in patients with and without coronary artery disease by programmed stimulation.
Clémenty J; Samoyeau R; Coste P; Bricaud H
J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S169-74. PubMed ID: 11527122
[TBL] [Abstract][Full Text] [Related]
36. Haemodynamic effects of a new beta-blocking agent 'Sectral' (M & B 17803A).
Lewis BS; Bakst A; Mitha AS; Purdon K; Gotsman MS
Br Heart J; 1973 Jul; 35(7):743-51. PubMed ID: 4146280
[No Abstract] [Full Text] [Related]
37. "Bisoprolol dose-response relationship in patients with congestive heart failure: a subgroup analysis in the cardiac insufficiency bisoprolol study(CIBIS II)," by Simon T.
Krum H; Hare D
Eur Heart J; 2004 Feb; 25(3):277. PubMed ID: 14972430
[No Abstract] [Full Text] [Related]
38. Recovery of the cardiac adrenergic nervous system after long-term beta-blocker therapy in idiopathic dilated cardiomyopathy: assessment by increase in myocardial 123I-metaiodobenzylguanidine uptake.
Lotze U; Kaepplinger S; Kober A; Richartz BM; Gottschild D; Figulla HR
J Nucl Med; 2001 Jan; 42(1):49-54. PubMed ID: 11197980
[TBL] [Abstract][Full Text] [Related]
39. [Beta blocking agents in the treatment of dilated cardiomyopathy: review of the literature and clinical experience with 67 patients].
Sinagra G; Perkan A; Di Lenarda A; Lardieri G; Pinamonti B; Mestroni L; Miani D; Camerini F
G Ital Cardiol; 1992 Aug; 22(8):969-89. PubMed ID: 1362167
[TBL] [Abstract][Full Text] [Related]
40. Is target dose the treatment target? Uptitrating beta-blockers for heart failure in the elderly.
Gelbrich G; Edelmann F; Inkrot S; Lainscak M; Apostolovic S; Neskovic AN; Waagstein F; Loeffler M; Anker SD; Dietz R; Düngen HD;
Int J Cardiol; 2012 Feb; 155(1):160-6. PubMed ID: 22133470
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
